INmune Bio, Inc. (NASDAQ:INMB) Q4 2024 Earnings Call Transcript March 27, 2025
INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.54.
Operator: Greetings, and welcome to the INmune Bio’s. 2024 Fourth Quarter and Full Year Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions]. As a reminder, this conference is being recorded, and the transcript will follow within 24 hours of this conference call. At this...
